Teknova to Report Third Quarter 2025 Financial Results on November 6, 2025

Rhea-AI Summary

Teknova (Nasdaq: TKNO) will report third quarter 2025 financial results for the quarter ended September 30, 2025, on Thursday, November 6, 2025 after market close.

The company will host a webcast and conference call on November 6, 2025, beginning at 5:00 p.m. Eastern Time. Investors can access the live webcast from the Investor Relations section of Teknova's website or by using the provided link, and participants can register to receive a unique PIN and dial-in information. A replay of the webcast will be available on the company website about two hours after the event.

HOLLISTER, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2025, on Thursday, November 6, 2025, following the close of market.

Teknova will host a webcast and conference call on Thursday, November 6, 2025, beginning at 5 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in molecular diagnostics, synthetic biology, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.

Investor Contact
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100 

Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259

This press release was published by a CLEAR® Verified individual.

FAQ

When will Teknova (TKNO) report Q3 2025 results?

Teknova will report third quarter 2025 results for the period ended September 30, 2025, on Thursday, November 6, 2025 after market close.

What time is the Teknova (TKNO) Q3 2025 webcast and conference call?

The webcast and conference call begins on November 6, 2025 at 5:00 p.m. Eastern Time.

How can investors access the Teknova (TKNO) live webcast for Nov 6, 2025?

Investors can access the live webcast via the Investor Relations section of Teknova's website or by using the link provided in the announcement.

Do I need to register to join the Teknova (TKNO) conference call on Nov 6, 2025?

Yes; registrants receive a unique PIN number and dial-in information to participate in the call.

Will a replay of the Teknova (TKNO) Q3 2025 webcast be available?

Yes; the webcast replay will be available on Teknova's website approximately two hours after the event.

What period does Teknova's Q3 2025 report cover?

The report covers the third quarter ended September 30, 2025.